Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- 15:45 - 16:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Luis Paz-Ares, Tina Cascone
-
+
Session Moderator
15:45 - 15:45 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Presenter: Tina Cascone
- Abstract
Loading... -
+
MA05.01 - Session Introduction
15:45 - 15:46 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
MA05.02 - Session Introduction
15:46 - 15:47 | Presenter: Tina Cascone
- Abstract
Loading... -
+
MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer
15:47 - 15:52 | Presenter: Wenbin Li
- Abstract
Loading... -
+
MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC
15:52 - 15:57 | Presenter: Max Wilhelm Backman
- Abstract
Loading... -
+
MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment
15:57 - 16:02 | Presenter: Xiaoli Liu
- Abstract
Loading... -
+
MA05.06 - Discussant
16:02 - 16:12 | Presenter: Fabio Pagni
- Abstract
Loading... -
+
MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping
15:57 - 16:02 | Presenter: Yuchen Han
- Abstract
Loading... -
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Presenter: Jennifer A. Marks
- Abstract
Loading... -
+
MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma
16:22 - 16:27 | Presenter: Harry Lengel
- Abstract
Loading... -
+
MA05.10 - Discussant
16:27 - 16:37 | Presenter: Giulia Pasello
- Abstract
Loading... -
+
MA05.11 - Live Q&A
16:37 - 16:45
- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
Presenter: Xiuning Le- Abstract
Loading...
-
+
ES28 - Neoadjuvant and Adjuvant Treatment of NSCLC in 2022
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Systemic Therapy (Multi-Modality Treatment, Immunotherapy, Molecular Targeted Treatments)
- Moderators:Tina Cascone, Mariano Provencio
-
+
Session Moderator
11:35 - 11:45 | Presenter: Tina Cascone
- Abstract
Loading... -
+
Session Moderator
11:35 - 11:45 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES28.01 - Session Introduction
10:45 - 10:46 | Presenter: Tina Cascone
- Abstract
Loading... -
+
ES28.02 - Session Introduction
10:46 - 10:47 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES28.03 - Surgical Techniques to Optimize Uptake of Adjuvant Treatment
10:47 - 10:59 | Presenter: Thomas D'Amico
- Abstract
Loading... -
+
ES28.04 - Standardisation of Pathological Assessment with Novel Neoadjuvant Therapies
10:59 - 11:11 | Presenter: Yasushi Yatabe
- Abstract
Loading... -
+
ES28.05 - How Does MRD Status Affect Decisions on Adjuvant Therapy?
11:11 - 11:23 | Presenter: Federico Cappuzzo
- Abstract
Loading... -
+
ES28.06 - Neoadjuvant EGFR TKI Trials
11:23 - 11:35 | Presenter: Julia Rotow
- Abstract
Loading... -
+
ES28.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...